Page 1 | Search Results | Blood | American Society of Hematology

1-11 of 11

Sort by

Sort Order Select

Journal Articles

Trends of Opioid Prescribing and Vaso-Occlusive Crises in Sickle Cell Disease in the U.S. (2011-2023)

Kevin Y Xu, Terri Victoria Newman, Lakeya S. McGill, Enrico M Novelli, Cheryl Hillery, Joanna L Buss, Ruizi Huang, Joanne Salas, Fanghong Dong, Dustin Stwalley, Shiyuan A Liu, Jeffrey Scherrer, Tashalee R Brown, Taewoo Park, Marc R Larochelle, Richard A Grucza, Charles R. Jonassaint

Blood (2024) 144 (Supplement 1): 5065.

https://doi.org/10.1182/blood-2024-209330

Published: 2024

Journal Articles

Gait speed, grip strength, and clinical outcomes in older patients with hematologic malignancies

Michael A. Liu, Clark DuMontier, Anays Murillo, Tammy T. Hshieh, Jonathan F. Bean, Robert J. Soiffer, Richard M. Stone, Gregory A. Abel, Jane A. Driver

Blood (2019) 134 (4): 374–382.

https://doi.org/10.1182/blood.2019000758

Published: 2019

Includes: Supplemental data

Journal Articles

Up to 7 Years of Follow-up of Single-Agent Ibrutinib in the Phase 1b/2 PCYC-1102 Trial of First Line and Relapsed/Refractory Patients with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

John C. Byrd, MD, Richard R. Furman, MD, Steven Coutre, MD, Ian W. Flinn, MD PhD, Jan A. Burger, MD PhD, Kristie A. Blum, MD, Jeff Sharman, MD, William G. Wierda, MD PhD, Weiqiang Zhao, MD PhD, Nyla A. Heerema, PhD, Ying Luan, PhD, Emily A. Liu, PhD, James P. Dean, MD PhD, Susan M. O'Brien, MD

Blood (2018) 132 (Supplement 1): 3133.

https://doi.org/10.1182/blood-2018-99-110847

Published: 2018

Journal Articles

Minimal residual disease monitoring by quantitative RT-PCR in core binding factor AML allows risk stratification and predicts relapse: results of the United Kingdom MRC AML-15 trial

John A. Liu Yin, Michelle A. O'Brien, Robert K. Hills, Sarah B. Daly, Keith Wheatley, Alan K. Burnett

Blood (2012) 120 (14): 2826–2835.

https://doi.org/10.1182/blood-2012-06-435669

Published: 2012

Includes: Supplemental data

Journal Articles

Stage IV adult sporadic Burkitt lymphoma/leukemia with complex bone marrow cytogenetics is associated with a very poor outcome

Eleni Tholouli, Simon Watt, Guy S. Lucas, John Burthem, John A. Liu Yin, Jim Cavet, Hayley Greenfield, John B. Houghton

Blood (2009) 114 (2): 485–486.

https://doi.org/10.1182/blood-2009-03-213231

Published: 2009

Journal Articles

Real-Time PCR Gene Expression Profiling of Microarray Gene Signatures in Acute Leukemia.

Ebrahim Sakhinia, PhD, Mahboubeh Farahangpour, BSc, John A. Liu Yin, MD, PhD, Gerard Brady, PhD, Judith A. Hoyland, PhD, Richard J. Byers, MD, PhD

Blood (2004) 104 (11): 4401.

https://doi.org/10.1182/blood.V104.11.4401.4401

Published: 2004

Journal Articles

Stimulation of autologous proliferative and cytotoxic T-cell responses by “leukemic dendritic cells” derived from blast cells in acute myeloid leukemia

Beth D. Harrison, Julie A. Adams, Mark Briggs, Michelle L. Brereton, John A. Liu Yin

Blood (2001) 97 (9): 2764–2771.

https://doi.org/10.1182/blood.V97.9.2764

Published: 2001

Journal Articles

Molecular quantitation of minimal residual disease in acute myeloid leukemia with t(8;21) can identify patients in durable remission and predict clinical relapse

K. Tobal, J. Newton, M. Macheta, J. Chang, G. Morgenstern, P. A. S. Evans, G. Morgan, G. S. Lucas, J. A. Liu Yin

Blood (2000) 95 (3): 815–819.

https://doi.org/10.1182/blood.V95.3.815.003k30_815_819

Published: 2000

Journal Articles

A Randomized, Double-Blind, Placebo-Controlled Study With Pegylated Recombinant Human Megakaryocyte Growth and Development Factor (PEG-rHuMGDF) as an Adjunct to Chemotherapy for Adults With De Novo Acute Myeloid Leukemia

Eric Archimbaud, Oliver G. Ottmann, John A. Liu Yin, Klaus Lechner, Herve Dombret, Miguel A. Sanz, Gerhard Heil, Pierre Fenaux, Wolfram Brugger, Alan Barge, Caroline O’Brien-Ewen, James Matcham, Dieter Hoelzer

Blood (1999) 94 (11): 3694–3701.

https://doi.org/10.1182/blood.V94.11.3694

Published: 1999

Journal Articles

A Randomized, Double-Blind, Placebo-Controlled, Phase III Study of Filgrastim in Remission Induction and Consolidation Therapy for Adults With De Novo Acute Myeloid Leukemia

Gerhard Heil, Dieter Hoelzer, Miguel A. Sanz, Klaus Lechner, John A. Liu Yin, Giuseppe Papa, Luc Noens, Jeff Szer, Arnold Ganser, Caroline O'Brien, James Matcham, Alan Barge

Blood (1997) 90 (12): 4710–4718.

https://doi.org/10.1182/blood.V90.12.4710

Published: 1997

Journal Articles

Effect of procaine HCLl on ATP: calcium-dependent alterations in red cell shape and deformability

J Palek, A Liu, D Liu, LM Snyder, NL Fortier, G Njoku, F Kiernan, D Funk, T Crusberg

Blood (1977) 50 (1): 155–164.

https://doi.org/10.1182/blood.V50.1.155.155

Published: 1977

NARROW

Trends of Opioid Prescribing and Vaso-Occlusive Crises in Sickle Cell Disease in the U.S. (2011-2023)

Gait speed, grip strength, and clinical outcomes in older patients with hematologic malignancies

Up to 7 Years of Follow-up of Single-Agent Ibrutinib in the Phase 1b/2 PCYC-1102 Trial of First Line and Relapsed/Refractory Patients with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

Minimal residual disease monitoring by quantitative RT-PCR in core binding factor AML allows risk stratification and predicts relapse: results of the United Kingdom MRC AML-15 trial

Stage IV adult sporadic Burkitt lymphoma/leukemia with complex bone marrow cytogenetics is associated with a very poor outcome

Real-Time PCR Gene Expression Profiling of Microarray Gene Signatures in Acute Leukemia.

Stimulation of autologous proliferative and cytotoxic T-cell responses by “leukemic dendritic cells” derived from blast cells in acute myeloid leukemia

Molecular quantitation of minimal residual disease in acute myeloid leukemia with t(8;21) can identify patients in durable remission and predict clinical relapse

A Randomized, Double-Blind, Placebo-Controlled Study With Pegylated Recombinant Human Megakaryocyte Growth and Development Factor (PEG-rHuMGDF) as an Adjunct to Chemotherapy for Adults With De Novo Acute Myeloid Leukemia

A Randomized, Double-Blind, Placebo-Controlled, Phase III Study of Filgrastim in Remission Induction and Consolidation Therapy for Adults With De Novo Acute Myeloid Leukemia

Effect of procaine HCLl on ATP: calcium-dependent alterations in red cell shape and deformability

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only